miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway
Publisher: Spandidos Publications
E-ISSN: 1791-2431|34|1|525-531
ISSN: 1021-335X
Source: Oncology Reports, Vol.34, Iss.1, 2015-01, pp. : 525-531
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract